Loading...

Pharmaceutical Outsourcing And Supply Chain Resilience Will Drive Future Expansion

Published
09 Feb 25
Updated
10 Sep 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-30.2%
7D
0.7%

Author's Valuation

CHF 110.6732.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 10 Sep 25

Fair value Decreased 0.45%

Siegfried Holding’s consensus analyst price target saw a marginal decrease to CHF110.67, as both revenue growth forecasts and discount rate assumptions remained effectively unchanged. What's in the News Siegfried Holding expects sales growth in the mid-single-digit percentage range in local currencies for 2025.

Shared on 23 Apr 25

Fair value Increased 14%

Shared on 17 Apr 25

Fair value Decreased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Increased 0.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Decreased 0.43%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Decreased 14%

AnalystConsensusTarget has decreased future PE multiple from 27.5x to 24.3x.